12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Antares, Leo Pharma sales and marketing update

Antares granted Leo exclusive, U.S. marketing rights to Otrexup methotrexate in dermatological indications. Antares will receive a $5 million upfront payment and is eligible for...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >